


Healthcare News Roundup: Oncology
HSMN NewsFeed - 24 Dec 2015
Eagle Pharmaceuticals Announces FDA Approval of Docetaxel Injection, Non-Alcohol Formula
Eagle Pharmaceuticals Announces FDA Approval of Docetaxel Injection, Non-Alcohol Formula
HSMN NewsFeed - 10 Dec 2015
Lilly and Merck Expand Immuno-Oncology Collaboration Adding Abemaciclib and KEYTRUDA(R) Combination Trial
Lilly and Merck Expand Immuno-Oncology Collaboration Adding Abemaciclib and KEYTRUDA(R) Combination Trial
HSMN NewsFeed - 7 Dec 2015
Syros Pharmaceuticals Appoints David A. Roth, M.D., as Chief Medical Officer
Syros Pharmaceuticals Appoints David A. Roth, M.D., as Chief Medical Officer
HSMN NewsFeed - 2 Dec 2015
Surefire Medical Closes $15M Series C Financing Led by Tullis Health Investors
Surefire Medical Closes $15M Series C Financing Led by Tullis Health Investors
HSMN NewsFeed - 30 Nov 2015
Proton Partners International to Fight Cancer with Elekta Radiotherapy Equipment
Proton Partners International to Fight Cancer with Elekta Radiotherapy Equipment
HSMN NewsFeed - 25 Nov 2015
Elekta: Karolinska University Hospital to Purchase Elekta’s Leksell Gamma Knife Icon
Elekta: Karolinska University Hospital to Purchase Elekta’s Leksell Gamma Knife Icon
HSMN NewsFeed - 19 Nov 2015
Triphase Accelerator Corporation Announces FDA Orphan Drug Designation for Marizomib in Malignant Glioma
Triphase Accelerator Corporation Announces FDA Orphan Drug Designation for Marizomib in Malignant Glioma
HSMN NewsFeed - 19 Nov 2015
Oncimmune Appoints Dr James Jett, World Recognised Lung Cancer Specialist, as Chief Medical Officer
Oncimmune Appoints Dr James Jett, World Recognised Lung Cancer Specialist, as Chief Medical Officer
HSMN NewsFeed - 18 Nov 2015
Amethyst Radiotherapy Orders Elekta Cancer Treatment Solutions for European Expansion
Amethyst Radiotherapy Orders Elekta Cancer Treatment Solutions for European Expansion
HSMN NewsFeed - 17 Nov 2015
ARCH Venture Partners, Flagship Ventures and MD Anderson Collaborate to Launch Codiak BioSciences
ARCH Venture Partners, Flagship Ventures and MD Anderson Collaborate to Launch Codiak BioSciences
HSMN NewsFeed - 13 Nov 2015
AbbVie Submits IMBRUVICA(R) (ibrutinib) Phase III Combination Data to U.S. FDA
AbbVie Submits IMBRUVICA(R) (ibrutinib) Phase III Combination Data to U.S. FDA
HSMN NewsFeed - 12 Nov 2015
Rosetta Provides Update on Performance Data and Launch of RosettaGX Reveal(TM) (Thyroid microRNA Classifier)
Rosetta Provides Update on Performance Data and Launch of RosettaGX Reveal(TM) (Thyroid microRNA Classifier)
HSMN NewsFeed - 12 Nov 2015
IntraOp Completes Delivery of IntraOp(R) Mobetron(R) Electron IORT System to Nanjing General Hospital
IntraOp Completes Delivery of IntraOp(R) Mobetron(R) Electron IORT System to Nanjing General Hospital
HSMN NewsFeed - 10 Nov 2015
Boston Scientific To Acquire Interventional Radiology Business Of CeloNova Biosciences
Boston Scientific To Acquire Interventional Radiology Business Of CeloNova Biosciences
HSMN NewsFeed - 4 Nov 2015
Flagship Ventures Launches Evelo Therapeutics To Develop Microbiome Therapies for Cancer
Flagship Ventures Launches Evelo Therapeutics To Develop Microbiome Therapies for Cancer
HSMN NewsFeed - 3 Nov 2015
Jounce Therapeutics Appoints Elizabeth Trehu, M.D., to Chief Medical Officer
Jounce Therapeutics Appoints Elizabeth Trehu, M.D., to Chief Medical Officer
